Literature DB >> 7851421

Presence of a closely related subgroup in the aldo-ketoreductase family of the mouse.

T Gui1, T Tanimoto, Y Kokai, C Nishimura.   

Abstract

Aldose reductase (alditol:NAD(P)+ 1-oxidoreductase), an enzyme implicated in the pathogenesis of various diabetic complications, catalyzes the reduction of a variety of aldehydes. From a mouse kidney library, we isolated aldose reductase cDNA that encodes a 316-amino-acid protein with approximately 97% identity to rat lens aldose reductase, approximately 69% identity to the mouse vas deferens protein and also approximately 69% identity to mouse fibroblast growth-factor-1-regulated protein. RNA-blot analysis demonstrated abundant expression of the enzyme transcript in the testis, skeletal muscle and kidney. However, a very low level of the transcript was detected in the sciatic nerve and lens, where abundant expression and involvement of the enzyme in diabetic complications were documented in other animals species. The isolated cDNA was expressed in Escherichia coli and the recombinant protein was purified to homogeneity by affinity chromatography and chromatofocusing. The expressed enzyme demonstrated reductase activity for various aldo sugars but not for the steroids. The enzyme reaction with DL-glyceraldehyde was, however, competitively inhibited by progesterone or 17 alpha-hydroxyprogesterone. The results not only indicate a unique tissue distribution and enzyme attribute of mouse aldose reductase, but also the presence of a closely related subgroup within the aldo-oxidoreductase superfamily in mouse tissues.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7851421     DOI: 10.1111/j.1432-1033.1995.tb20408.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  11 in total

1.  Preparation and characterization of polyclonal antibodies against ARL-1 protein.

Authors:  Jun-Fei Jin; Liu-Di Yuan; Li Liu; Zhu-Jiang Zhao; Wei Xie
Journal:  World J Gastroenterol       Date:  2003-07       Impact factor: 5.742

Review 2.  The aldo-keto reductase superfamily and its role in drug metabolism and detoxification.

Authors:  Oleg A Barski; Srinivas M Tipparaju; Aruni Bhatnagar
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

Review 3.  Comparative anatomy of the aldo-keto reductase superfamily.

Authors:  J M Jez; M J Bennett; B P Schlegel; M Lewis; T M Penning
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

4.  Aldo-keto reductase family 1 member B8 is secreted via non-classical pathway.

Authors:  Zhenwang Tang; Chenglai Xia; Renbin Huang; Xiaoning Li; Wan-Chun Wang; Wangyuan Guo; Lili Duan; Weihao Luo; Deliang Cao; Di-Xian Luo
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

5.  Differential control of murine aldose reductase and fibroblast growth factor (FGF)-regulated-1 gene expression in NIH 3T3 cells by FGF-1 treatment and hyperosmotic stress.

Authors:  D K Hsu; Y Guo; K A Peifley; J A Winkles
Journal:  Biochem J       Date:  1997-12-01       Impact factor: 3.857

6.  Identification of a renal-specific oxido-reductase in newborn diabetic mice.

Authors:  Q Yang; B Dixit; J Wada; Y Tian; E I Wallner; S K Srivastva; Y S Kanwar
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

7.  Human and rodent aldo-keto reductases from the AKR1B subfamily and their specificity with retinaldehyde.

Authors:  F Xavier Ruiz; Armando Moro; Oriol Gallego; Albert Ardèvol; Carme Rovira; J Mark Petrash; Xavier Parés; Jaume Farrés
Journal:  Chem Biol Interact       Date:  2011-02-15       Impact factor: 5.192

8.  Tissue-specific expression of two aldose reductase-like genes in mice: abundant expression of mouse vas deferens protein and fibroblast growth factor-regulated protein in the adrenal gland.

Authors:  E T Lau; D Cao; C Lin; S K Chung; S S Chung
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

9.  Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency.

Authors:  S Ii; M Ohta; E Kudo; T Yamaoka; T Tachikawa; M Moritani; M Itakura; K Yoshimoto
Journal:  Diabetologia       Date:  2004-02-14       Impact factor: 10.122

10.  Aldo-Keto Reductases 1B in Endocrinology and Metabolism.

Authors:  Emilie Pastel; Jean-Christophe Pointud; Fanny Volat; Antoine Martinez; Anne-Marie Lefrançois-Martinez
Journal:  Front Pharmacol       Date:  2012-08-02       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.